Details of the Drug
General Information of Drug (ID: DMKDZH4)
Drug Name |
AcAsp-Glu-Leu-Glu-Cha-Cys
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
AcAsp-Glu-Leu-Glu-Cha-Cys; CHEMBL305570; AC1LAON7; Ac-Asp-Glu-Leu-Glu-Cha-Cys-OH; BDBM50096404; AcAsp-Glu-Leu-Glu-.beta.-Cyclohexylalanine-Cys; Ac-Asp-Glu-Leu-Glu-beta-Cyclohexylalanine-Cys-OH; Ac-L-Asp-Glu-L-Leu-L-Glu-3-Cyclohexyl-L-Ala-L-Cys-OH; (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-4-hydroxy-4-oxobutanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-5-[[(2S)-3-cyclohexyl-1-[[(2R)-1-hydroxy-1-oxo-3-sulfanylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 4 | Molecular Weight (mw) | 802.9 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 25 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 11 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 15 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||